Renalytix Plc (AIM: RENX)
London
· Delayed Price · Currency is GBP · Price in GBX
11.50
-0.75 (-6.12%)
Jan 20, 2025, 3:29 PM GMT+1
Renalytix Revenue
Renalytix had revenue of $522.00K USD in the quarter ending September 30, 2024, with 13.73% growth. This brings the company's revenue in the last twelve months to $2.35M, down -18.70% year-over-year. In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M, down -32.74%.
Revenue (ttm)
$2.35M
Revenue Growth
-18.70%
P/S Ratio
7.27
Revenue / Employee
$23.06K
Employees
102
Market Cap
38.09M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Renalytix News
- 2 months ago - Renalytix AI reports Q1 results - Seeking Alpha
- 2 months ago - Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 - PRNewsWire
- 6 months ago - Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US - GlobeNewsWire
- 7 months ago - Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - GlobeNewsWire
- 7 months ago - Medicare Issues Final Coverage Determination for kidneyintelX.dkd - GlobeNewsWire
- 8 months ago - Renalytix Plc (RNLX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024 - GlobeNewsWire
- 9 months ago - Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 - GlobeNewsWire